| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |